MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated Total Liabilities 2011-2026 | ARAY
Annual Total Liabilities Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 389 M | 424 M | 426 M | 420 M | 411 M | 427 M | 388 M | 330 M | 360 M | 409 M | 394 M | 397 M | 369 M | 269 M | 215 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 427 M | 215 M | 375 M |
Quarterly Total Liabilities Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 395 M | 395 M | 389 M | 435 M | 430 M | 428 M | 424 M | 421 M | 429 M | 426 M | 426 M | 421 M | 417 M | 419 M | 420 M | 418 M | 425 M | 430 M | 411 M | 411 M | 400 M | 397 M | 427 M | 427 M | 423 M | 423 M | 388 M | 388 M | 340 M | 322 M | 330 M | 330 M | 365 M | 345 M | 360 M | 360 M | 369 M | 369 M | 409 M | 409 M | 412 M | 398 M | 391 M | 394 M | 392 M | 379 M | 397 M | 397 M | 390 M | 378 M | 369 M | 369 M | 265 M | 269 M | 269 M | 269 M | 261 M | 261 M | 215 M | 215 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 435 M | 215 M | 377 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
27.2 M | $ 3.22 | - | $ 121 M |  France |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 93.7 | -1.24 % | $ 12.7 B | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.12 | -1.85 % | $ 1.29 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
87.2 M | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.84 | - | $ 388 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 37.87 | -1.23 % | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 83.46 | -0.94 % | $ 48.8 B | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.34 | -2.62 % | $ 494 M | USA |
 |
NanoVibronix
NAOV
|
7.63 M | - | - | $ 1.08 M | USA |
 |
Nevro Corp.
NVRO
|
323 M | - | - | $ 217 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.83 | 0.8 % | $ 34.7 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Natus Medical Incorporated
NTUS
|
140 M | - | 1.94 % | $ 1.05 B | USA |
 |
Orthofix Medical
OFIX
|
401 M | $ 12.32 | -0.24 % | $ 488 M |  Curacao |